Summary Hutchison MediPharma Ltd (HMPL), a subsidiary of Hutchison China MediTech Ltd is a biopharmaceutical company that discovers, develops and commercializes therapeutics in oncology and autoimmune diseases. The company’s products comprise savolitinib, fruquintinib, sulfatinib, hmpl-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004.
It develops drug discovery technologies in molecular and cell biology, high throughput screening, genomics and informatics to support research and development projects. HMPL’s research and development programs comprise gene-targeted and cell-based screening assays, ligand-dependent screening assays and signal transduction pathway screening assays. The company’s products serve in fields of medicinal chemistry, pharmacology, oncology, cardiovascular and respiratory diseases, and antiviral treatments. HMPL is headquartered in Pudong, China.
Hutchison MediPharma Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope - Financial Deals - Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company’s operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Our reports have been used by over 10K customers, including:
Interleukin 1 (IL1) - Drugs in Development, 2021 Summary According to the recently published report ’Interleukin 1 - Drugs in Development, 2021’; Interleukin 1 (IL1) pipeline Target constitutes close to 36 molecules. Out of which approximately 35 molecules are developed by companies and remaining...
The Quantum Computing market is expected to grow from USD 472 million in 2021 to USD 1,765 million by 2026, at a CAGR of 30.2%. The early adoption of quantum computing in the banking and finance sector is expected to fuel the growth of the market globally. Other key factors contributing to the growth of the quantum computing market include...
The global contract lifecycle management software market reached a value of US$ 1.51 Billion in 2020. Contract lifecycle management (CLM) software assists in efficiently managing the complete process of a contract signed between two or more organizations. It comprises of eight vital steps: contract drafting, negotiation, approval, compliance...
172 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global D-Amino Acids Market to Reach $227.7 Million by 2027
- Amid the COVID-19 crisis, the global market for D-Amino Acids estimated at US$178.3 Million in the year 2020, is projected to reach a revised size of US$227.7 Million by 2027, growing at a CAGR of 3.6% over the analysis period 2020-2027. Pharmaceutical,...
139 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Q-TOF Mass Spectrometry Market to Reach $1.2 Billion by 2027
- Amid the COVID-19 crisis, the global market for Q-TOF Mass Spectrometry estimated at US$786.5 Million in the year 2020, is projected to reach a revised size of US$1.2 Billion by 2027, growing at a CAGR of 6.3% over the analysis period...
185 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Ionic Liquids Market to Reach $55.4 Million by 2027
- Amid the COVID-19 crisis, the global market for Ionic Liquids estimated at US$32.5 Million in the year 2020, is projected to reach a revised size of US$55.4 Million by 2027, growing at a CAGR of 7.9% over the analysis period 2020-2027. Solvents...
188 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Flexible Intermediate Bulk Container Market to Reach 980.8 Million Units by 2027
- Amid the COVID-19 crisis, the global market for Flexible Intermediate Bulk Container estimated at 702.2 Million Units in the year 2020, is projected to reach a revised size of 980.8 Million Units by 2027, growing at...
190 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Sodium Cyanide Market to Reach $2.8 Billion by 2027
- Amid the COVID-19 crisis, the global market for Sodium Cyanide estimated at US$1.9 Billion in the year 2020, is projected to reach a revised size of US$2.8 Billion by 2027, growing at a CAGR of 5.3% over the analysis period 2020-2027. Mining,...
287 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Carbohydrase Market to Reach $5.3 Billion by 2027
- Amid the COVID-19 crisis, the global market for Carbohydrase estimated at US$3.7 Billion in the year 2020, is projected to reach a revised size of US$5.3 Billion by 2027, growing at a CAGR of 5.5% over the analysis period 2020-2027. Food & Beverage,...
186 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Levulinic Acid Market to Reach $49.2 Million by 2027
- Amid the COVID-19 crisis, the global market for Levulinic Acid estimated at US$21.3 Million in the year 2020, is projected to reach a revised size of US$49.2 Million by 2027, growing at a CAGR of 12.7% over the analysis period 2020-2027. Agriculture,...
Food Additive
Pharmaceutical
World
China
United States
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.